51067 2 ap proteintech rabbit anti phospho beta catenin ser675 (Proteintech)
Proteintech is a verified supplier 
96
Structured Review
Proteintech
51067 2 ap proteintech rabbit anti phospho beta catenin ser675
51067 2 Ap Proteintech Rabbit Anti Phospho Beta Catenin Ser675, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1623 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+proteintech+%CE%B2+catenin/beta-Catenin+Antibody/10__22175_slash_mmb__21148-729-117-118
Average 96 stars, based on 1623 article reviews
51067 2 Ap Proteintech Rabbit Anti Phospho Beta Catenin Ser675, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1623 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+proteintech+%CE%B2+catenin/beta-Catenin+Antibody/10__22175_slash_mmb__21148-729-117-118
Average 96 stars, based on 1623 article reviews
51067 2 ap proteintech rabbit anti phospho beta catenin ser675 - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Microarray:Article Title: YBX1 Promotes Esophageal Squamous Cell Carcinoma Progression via m5C‐Dependent SMOX mRNA Stabilization Article Snippet: .. Table S1 Clinico-pathological characteristics of ESCC patients Table S2 GEO microarray data enrolled in this study Accession number Platform Number of samples Country Years Non-tumor ESCC GSE5364 Affymetrix 13 16 Singapore 2018 GSE20347 Affymetrix 17 17 USA 2018 GSE23400 Affymetrix 104 104 USA 2019 GSE38129 Affymetrix 30 30 USA 2018 GSE92396 Affymetrix 9 12 USA 2018 GSE89102 Agilent 5 5 China 2016 GSE13898 Illumina 28 64 USA 2011 Total 206 248 Clinico-pathological characters Number. of cases (n) YBX1 expression X 2 P Value Low High Age (years) ≤60 30 18 12 0.189 0.664 >60 77 32 45 Gender Male 82 37 45 2.949 0.086 Female 26 13 13 Tumor size T1-2 20 11 9 0.797 0.372 T3-4 82 36 46 Node N0 35 17 18 0.507 0.476 N1-2 42 17 25 TNM stage Stage I-II 49 24 25 0.212 0.645 Stage III-IV 54 24 30 Table S3 Information on antibodies used in this study Antibody IHC Western blot Specificity Company YBX1 1:200 1:1000 Rabbit Abcam NSUN2 1:200 1:4000 Rabbit Proteintech SMOX 1:200 1:1000 Rabbit Proteintech GAPDH / 1:5000 Mouse Proteintech NOP2 / 1:1000 Rabbit Proteintech NSUN3 / 1:1000 Rabbit Abclonal NSUN4 / 1:1000 Rabbit Abclonal NSUN5 / 1:1000 Rabbit Abclonal NSUN6 / 1:1000 Rabbit Proteintech NSUN7 / 1:800 Rabbit Proteintech DNMT3A / 1:5000 Rabbit Proteintech TET2 / 1:1000 Expressing:Article Title: YBX1 Promotes Esophageal Squamous Cell Carcinoma Progression via m5C‐Dependent SMOX mRNA Stabilization Article Snippet: .. Table S1 Clinico-pathological characteristics of ESCC patients Table S2 GEO microarray data enrolled in this study Accession number Platform Number of samples Country Years Non-tumor ESCC GSE5364 Affymetrix 13 16 Singapore 2018 GSE20347 Affymetrix 17 17 USA 2018 GSE23400 Affymetrix 104 104 USA 2019 GSE38129 Affymetrix 30 30 USA 2018 GSE92396 Affymetrix 9 12 USA 2018 GSE89102 Agilent 5 5 China 2016 GSE13898 Illumina 28 64 USA 2011 Total 206 248 Clinico-pathological characters Number. of cases (n) YBX1 expression X 2 P Value Low High Age (years) ≤60 30 18 12 0.189 0.664 >60 77 32 45 Gender Male 82 37 45 2.949 0.086 Female 26 13 13 Tumor size T1-2 20 11 9 0.797 0.372 T3-4 82 36 46 Node N0 35 17 18 0.507 0.476 N1-2 42 17 25 TNM stage Stage I-II 49 24 25 0.212 0.645 Stage III-IV 54 24 30 Table S3 Information on antibodies used in this study Antibody IHC Western blot Specificity Company YBX1 1:200 1:1000 Rabbit Abcam NSUN2 1:200 1:4000 Rabbit Proteintech SMOX 1:200 1:1000 Rabbit Proteintech GAPDH / 1:5000 Mouse Proteintech NOP2 / 1:1000 Rabbit Proteintech NSUN3 / 1:1000 Rabbit Abclonal NSUN4 / 1:1000 Rabbit Abclonal NSUN5 / 1:1000 Rabbit Abclonal NSUN6 / 1:1000 Rabbit Proteintech NSUN7 / 1:800 Rabbit Proteintech DNMT3A / 1:5000 Rabbit Proteintech TET2 / 1:1000 Immunohistochemistry:Article Title: YBX1 Promotes Esophageal Squamous Cell Carcinoma Progression via m5C‐Dependent SMOX mRNA Stabilization Article Snippet: .. Table S1 Clinico-pathological characteristics of ESCC patients Table S2 GEO microarray data enrolled in this study Accession number Platform Number of samples Country Years Non-tumor ESCC GSE5364 Affymetrix 13 16 Singapore 2018 GSE20347 Affymetrix 17 17 USA 2018 GSE23400 Affymetrix 104 104 USA 2019 GSE38129 Affymetrix 30 30 USA 2018 GSE92396 Affymetrix 9 12 USA 2018 GSE89102 Agilent 5 5 China 2016 GSE13898 Illumina 28 64 USA 2011 Total 206 248 Clinico-pathological characters Number. of cases (n) YBX1 expression X 2 P Value Low High Age (years) ≤60 30 18 12 0.189 0.664 >60 77 32 45 Gender Male 82 37 45 2.949 0.086 Female 26 13 13 Tumor size T1-2 20 11 9 0.797 0.372 T3-4 82 36 46 Node N0 35 17 18 0.507 0.476 N1-2 42 17 25 TNM stage Stage I-II 49 24 25 0.212 0.645 Stage III-IV 54 24 30 Table S3 Information on antibodies used in this study Antibody IHC Western blot Specificity Company YBX1 1:200 1:1000 Rabbit Abcam NSUN2 1:200 1:4000 Rabbit Proteintech SMOX 1:200 1:1000 Rabbit Proteintech GAPDH / 1:5000 Mouse Proteintech NOP2 / 1:1000 Rabbit Proteintech NSUN3 / 1:1000 Rabbit Abclonal NSUN4 / 1:1000 Rabbit Abclonal NSUN5 / 1:1000 Rabbit Abclonal NSUN6 / 1:1000 Rabbit Proteintech NSUN7 / 1:800 Rabbit Proteintech DNMT3A / 1:5000 Rabbit Proteintech TET2 / 1:1000 Western Blot:Article Title: YBX1 Promotes Esophageal Squamous Cell Carcinoma Progression via m5C‐Dependent SMOX mRNA Stabilization Article Snippet: .. Table S1 Clinico-pathological characteristics of ESCC patients Table S2 GEO microarray data enrolled in this study Accession number Platform Number of samples Country Years Non-tumor ESCC GSE5364 Affymetrix 13 16 Singapore 2018 GSE20347 Affymetrix 17 17 USA 2018 GSE23400 Affymetrix 104 104 USA 2019 GSE38129 Affymetrix 30 30 USA 2018 GSE92396 Affymetrix 9 12 USA 2018 GSE89102 Agilent 5 5 China 2016 GSE13898 Illumina 28 64 USA 2011 Total 206 248 Clinico-pathological characters Number. of cases (n) YBX1 expression X 2 P Value Low High Age (years) ≤60 30 18 12 0.189 0.664 >60 77 32 45 Gender Male 82 37 45 2.949 0.086 Female 26 13 13 Tumor size T1-2 20 11 9 0.797 0.372 T3-4 82 36 46 Node N0 35 17 18 0.507 0.476 N1-2 42 17 25 TNM stage Stage I-II 49 24 25 0.212 0.645 Stage III-IV 54 24 30 Table S3 Information on antibodies used in this study Antibody IHC Western blot Specificity Company YBX1 1:200 1:1000 Rabbit Abcam NSUN2 1:200 1:4000 Rabbit Proteintech SMOX 1:200 1:1000 Rabbit Proteintech GAPDH / 1:5000 Mouse Proteintech NOP2 / 1:1000 Rabbit Proteintech NSUN3 / 1:1000 Rabbit Abclonal NSUN4 / 1:1000 Rabbit Abclonal NSUN5 / 1:1000 Rabbit Abclonal NSUN6 / 1:1000 Rabbit Proteintech NSUN7 / 1:800 Rabbit Proteintech DNMT3A / 1:5000 Rabbit Proteintech TET2 / 1:1000 |